Atrozole

INDICATIONS :
Anastrozole (ATROZOLE) is indicated for the treatment of advance breast cancer in postmenopausal women (in patients with
estrogen receptor-negative patients who do not show a clinical response to tamoxifen treatment prior to this therapy, the
efficacy of this drug has not been proven).
It is also used as an adjuvant treatment of early breast cancer in postmenopausal women with hormone receptor positive:
early treatment of early breast cancer for receptor positive postmenopausal.

Packaging: Box of 28’s
Shelf Life: 60 mos
Origin: Korea
Regional MOQ: 6,250